MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Biosimilars and Bioanalytical Methods
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

876 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
876 works in the cohort · of 4,299,418page 10 of 18

Labels cover 4 of 876 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 876 of 876 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

fundno affunlabeled
Post-approval Variations to Dossiers for Vaccines: Analysis of Regulatory and Methodological Approaches Used in the Russian Federation and Abroad
В. А. Шевцов, Yu. V. Olefir, В. А. Меркулов, В. П. Бондарев, Ivana Indiková, E. E. Evreinova +3 more
2019· article· en· The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation· Immunology and Microbiology
distilled prediction:candidate · metaresearchconsensus · metaresearch
2
citations
affno abstractunlabeled
AB0198 EFFICACY AND SAFETY AFTER TRANSITION FROM REFERENCE ADALIMUMAB TO CT-P17 (ADALIMUMAB BIOSIMILAR: 100 MG/ML) IN COMPARISON WITH THE MAINTAINED TREATMENT (CT-P17 OR REFERENCE ADALIMUMAB) IN PATIENTS WITH MODERATE-TO-SEVERE ACTIVE RHEUMATOID ARTHRITIS: 1-YEAR RESULT
Daniel E. Furst, Edward Keystone, Jonathan Kay, Janusz Jaworski, Rafał Wojciechowski, Piotr Wiland +14 more
2021· article· en· Annals of the Rheumatic Diseases· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrowconsensus · none
2
citations
affno abstractunlabeled
Biosimilars: Promises Made. Promises Kept?
Sylvia Aidé Martínez‐Cabriales, Rachael Manion, Neil H. Shear
2021· article· en· Journal of Cutaneous Medicine and Surgery· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · none
2
citations
affunlabeled
2024 White paper on recent issues in bioanalysis: Impact of LDT in US and IVDR in EU; AI/ML for High Parameter Flow Cytometry; The rise of Olink Technology; CDx for AAV Gene Therapies; Integrative Bioanalysis by Multiple Platforms; Super Sensitive ADA/NAb LBA ( <u>PART 2A</u> – Recommendations on Advanced Strategies for Biomarkers, IVD/CDx Assays (BAV), Cell Based Assays (CBA), and Ligand-Binding Assays (LBA) <u>PART 2B</u> – Regulatory Agencies’ Input on Biomarkers, IVD/CDx, and Biomarker Assay Validation)
Nicoletta Bivi, Danielle Graham, Laura Joglekar, Kristina McGuire, Jeroen N. Stoop, Jad Zoghbi +56 more
2025· article· en· Bioanalysis· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrowconsensus · none
2
citations
affno abstractunlabeled
Interchangeabilité et substitution des biosimilaires
A. Astier
2020· review· fr· Annales Pharmaceutiques Françaises· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+sts+research_integrity+insufficient_payloadconsensus · metaepi_narrow+research_integrity+insufficient_payload
2
citations
affunlabeled
Incorporating Biologics into the Treatment of Psoriasis
Harvey Lui, Richard G. Langley, Yves Poulin, Aditya K. Gupta, Wayne Carey, Lyn Guenther +5 more
2004· review· en· Journal of Cutaneous Medicine and Surgery· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Evaluación crítica y meta-análisis de estudios de variación biológica para albúmina glicosilada, glucosa y HbA<sub>1c</sub>
Carmen Ricós, Pilar Fernández–Calle, Elisabet González-Lao, Margarida Simón, Jorge Díaz–Garzón, Beatriz Boned +10 more
2020· article· es· Advances in Laboratory Medicine / Avances en Medicina de Laboratorio· Immunology and Microbiology
distilled prediction:candidate · metaresearch+metaepi_narrow+sts+research_integrity+insufficient_payloadconsensus · metaepi_narrow+research_integrity
1
citations
affunlabeled
17th GCC Closed Forum: Integrative Bioanalysis, Patient-centric Sampling, Emerging Technologies, Data Integrity, Sample Reconciliation, Discrepancies of ELISpot Data, Cross-validation Harmonization, Ultrasensitive Platforms for ADA Assays, Remote Regulatory Assessments, Shedding Assays by PCR, and Biomarker Tissue Assays
Jennifer Zimmer, Mark Odell, Amanda Hays, Shashank Gorityala, Magdalena Tary‐Lehmann, Manisha R. Diaz +37 more
2025· article· en· Bioanalysis· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrowconsensus · none
1
citations
aboutno affunlabeled
Biologics in Plaque Psoriasis
Peter Dyrda, Sirjana Pant
2021· article· en· Canadian Journal of Health Technologies· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
1
citations
affno abstractunlabeled
POS0899 FIRST-IN-HUMAN SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS DATA WITH MK-6194, A MODIFIED FORM OF INTERLEUKIN-2, DESIGNED TO SELECTIVELY ACTIVATE REGULATORY T-CELLS – SINGLE ASCENDING DOSE AND MULTIPLE ASCENDING DOSE TRIALS
J. E. SCHEID, Amy Cunningham‐Bussel, Nikita Kim, Subhash Mohan Agarwal, Garrett Nieddu, J. Cote +27 more
2024· article· en· Annals of the Rheumatic Diseases· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
1
citations
affunlabeled
Neutralizing Antibody Sample Testing and Report Harmonization
Darshana Jani, Michele Gunsior, Robin Marsden, Kyra J. Cowan, Susan C. Irvin, Laura Schild Hay +29 more
2024· article· en· The AAPS Journal· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
1
citations
venueno affno abstractunlabeled
Les produits biologiques: aperçu
Leigh Revers, Eva Furczon
2010· article· fr· Canadian Pharmacists Journal / Revue des Pharmaciens du Canada· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+sts+research_integrity+insufficient_payloadconsensus · none
1
citations
venueno affno abstractunlabeled
Making the Most of Opportunities in Veterinary Pharmacy
Rosemary Killeen
2006· article· en· Canadian Pharmacists Journal / Revue des Pharmaciens du Canada· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · none
1
citations
affaboutunlabeled
P417 Frequent Early Nocebo Complaints but Maintained Clinical Efficacy, Biomarker and Therapeutic drug levels following mandatory Biosimilar Switch in Patients with Inflammatory Bowel disease: Preliminary data from a Prospective Observational Cohort Study
Panu Wetwittayakhlang, K Karkout, Paraskevi Tselekouni, Reem Al-Jabri, Talat Bessissow, Waqqas Afif +2 more
2023· article· en· Journal of Crohn s and Colitis· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
1
citations
← previousnext →

How this was built: Screen · Findings · About